Artificial intelligence and big data applications in chronic disease management: clinical outcomes, challenges, and future directions

<p><strong>Aim: </strong>To synthesize applications of Artificial Intelligence (AI) and big data in chronic disease management, evaluate clinical and economic outcomes, challenges, and future directions.</p> <p><strong>Methods: </strong>A comprehensive search was conducted across PubMed, Scopus, Web of Science, IEEE Xplore, and CINAHL for studies published between 2015-2025, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines.This review was registered in PROSPERO (CRD420251036828). Inclusion criteria encompassed peer-reviewed empirical, narrative, and systematic studies focused on AI and big data in chronic diseases care. Twelve studies were appraised using validated appraisal tools appropriate to each the study design, which conducted across clinical, technological and public health setting, reflecting application of AI and big data in hospital, digital health platform and diseases management.</p> <p><strong>Results: </strong>AI models achieved predictive accuracies between 88%-96% across diabetes, Chronic Kidney Disease (CKD), chronic obstructive pulmonary disease (COPD), and cardiovascular conditions. Outcomes included a 25% reduction in readmissions, a 30% decrease in CKD progression, and a 25% improvement in treatment adherence. Technologies included machine learning, electronic health record integration, wearable devices, and multi-omics platforms. Major challenges identified were data fragmentation, bias, and regulatory gaps.</p> <p><strong>Conclusion: </strong>The AI and big data offer transformative potential for chronic disease management from early prediction to personalized treatment, but realizing this requires addressing data fragmentation, ethical and privacy concerns, and ensuring equity and accountability through transparent, explainable AI.</p> <p><strong>Keywords: </strong>Artificial Intelligence, big data, chronic disease, machine learning, clinical decision support systems</p> <p> </p>

Authors

Institutions

Publication Details

Journal
Medicinski Glasnik
Published
2026-02-27
DOI
https://doi.org/10.17392/2061-23-01
Primary Topic
Artificial Intelligence in Healthcare and Education
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Artificial intelligence and big data applications in chronic disease management: clinical outcomes, challenges, and future directions

Muayyad M Ahmad, Sana'a Abu-Qbeitah
Medicinski Glasnik
Artificial Intelligence in Healthcare and Education
article

Artificial intelligence and big data applications in chronic disease management: clinical outcomes, challenges, and future directions

Muayyad M Ahmad, Sana'a Abu-Qbeitah
article en

Abstract

<p><strong>Aim: </strong>To synthesize applications of Artificial Intelligence (AI) and big data in chronic disease management, evaluate clinical and economic outcomes, challenges, and future directions.</p> <p><strong>Methods: </strong>A comprehensive search was conducted across PubMed, Scopus, Web of Science, IEEE Xplore, and CINAHL for studies published between 2015-2025, following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 2020 guidelines.This review was registered in PROSPERO (CRD420251036828). Inclusion criteria encompassed peer-reviewed empirical, narrative, and systematic studies focused on AI and big data in chronic diseases care. Twelve studies were appraised using validated appraisal tools appropriate to each the study design, which conducted across clinical, technological and public health setting, reflecting application of AI and big data in hospital, digital health platform and diseases management.</p> <p><strong>Results: </strong>AI models achieved predictive accuracies between 88%-96% across diabetes, Chronic Kidney Disease (CKD), chronic obstructive pulmonary disease (COPD), and cardiovascular conditions. Outcomes included a 25% reduction in readmissions, a 30% decrease in CKD progression, and a 25% improvement in treatment adherence. Technologies included machine learning, electronic health record integration, wearable devices, and multi-omics platforms. Major challenges identified were data fragmentation, bias, and regulatory gaps.</p> <p><strong>Conclusion: </strong>The AI and big data offer transformative potential for chronic disease management from early prediction to personalized treatment, but realizing this requires addressing data fragmentation, ethical and privacy concerns, and ensuring equity and accountability through transparent, explainable AI.</p> <p><strong>Keywords: </strong>Artificial Intelligence, big data, chronic disease, machine learning, clinical decision support systems</p> <p> </p>

Medicinski GlasnikVol. 23(1)
Al-Hussein Bin Talal University (JO), University of Jordan (JO)
Openalex Percentile: Top 43%
Artificial Intelligence in Healthcare and Education
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.